Skip to main content
Log in

Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080

  • Original Article
  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The effects of CGS 13080, a thromboxane (TXA2) synthase inhibitor, on airway responses to arachidonic acid (AA) were investigated in the anesthetized cat. Feline and human lung microsomal fraction exhibited prostaglandin I2 (PGI2, prostacyclin), and TXA2 synthase activities, and human platelet microsomal fractions exhibited TXA2 synthase activity. Cat and human lung microsomal fractions, but not human platelets, exhibited the presence of GSH-dependent PGE2 isomerase activity. CGS 13080 inhibited TXA2 synthase activity in all three microsomal fractions in a concentration-dependent manner. The increases in transpulmonary pressure and lung resistance and decreases in dynamic compliance in response to AA were decreased significantly by CGS 13080. These data suggest that the bronchoconstrictor actions of AA are mediated in large part by the formation of TXA2. The data further indicate that cyclooxygenase products other than TXA2 are involved in the bronchoconstrictor response to AA since meclofenamate had greater inhibitory activity than did CGS 13080. Moreover, the effects of CGS 13080 were due to inhibition of TXA2 synthase rather than an effect on TXA2 receptors, since airway responses to the TXA2 mimic, U46619, were not altered. The present data show that CGS 13080 inhibits TXA2 synthase activity without altering cyclooxygenase, PGI2 synthase, or GSH-dependent PGE2 isomerase activities. The data further indicate that in vivo administration of CGS 13080 may selectively increase PGI2 synthase activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kadowitz PJ, Hyman AL: Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed. Circ Res 40:282–287, 1977

    Google Scholar 

  2. Kadowitz PJ, Chapnick BM, Feigen LP, Hyman AL, Nelson PK, Spannhake E W. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol 45:408–413, 1978

    Google Scholar 

  3. Levin JL, Spannhake EW, Hyman AL, Kadowitz PJ: Analysis of airway responses to dihomo-γ-linolenic acid in the cat. J Pharmacol Exp Ther 223:169–176, 1982

    Google Scholar 

  4. Spannhake EW, Lemen RJ, Wegmann MJ, Hyman AL, Kadowitz PJ: Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J Appl Physiol 44:397–495, 1978

    Google Scholar 

  5. Spannhake EW Levin JL, Mellion BT, Gruetter CA, Hyman AL, Kadowitz PJ: Reversal of 5-HT-induced bronchoconstriction by PGI2. Distribution of central and peripheral actions. J Appl Physiol 49:521–527, 1980

    Google Scholar 

  6. She HS, McNamara D, Spannhake EW, Hyman AL, Kadowitz PJ: Metabolism of prostaglandin endoperoxide by microsomes from cat lung. Prostaglandins 21:531–541, 1981

    Google Scholar 

  7. Wasserman MA, DuCharme DW, Griffin RL, De Graff GL, Robinson FG: Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. Prostaglandins 13:255–265, 1977

    Google Scholar 

  8. Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FA: Synthesis and structure of the platelet aggregating factor thromboxane A2. Nature 315:511–513, 1985

    Google Scholar 

  9. Dahlen SE: Pulmonary effects of leukotrienes. Acta Physiol Scand 512:1–10, 1983

    Google Scholar 

  10. Graybar GB, Harrington JK, Cowen KH, Spannhake EW, Hyman AL, McNamara DB, Kadowitz PJ: Cyclooxygenase mediated airway response to leukotriene D4 in the cat. Prostaglandins 31:167–177, 1986

    Google Scholar 

  11. Kadowitz PJ, Hyman AL: Analysis of responses to leukotriene D4 in the pulmonary vascular bed. Ore Res 55:707–717, 1984

    Google Scholar 

  12. Demling RH, Smith M, Gunther R, Flynn JT, Gee M: Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol 240:H348-H353, 1981

    Google Scholar 

  13. Dusting GJ, Moncada S, Vane JR: Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems. Prog Cardiovasc Dis 21:405–414, 1979

    Google Scholar 

  14. Hales CA, Stonne L, Peterson M, Kong D, Miller M, Walkens WD: Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 68:497–505, 1981

    Google Scholar 

  15. Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Res 30:293–323, 1979

    Google Scholar 

  16. Piper P, Vane JR: The release of prostaglandins from lung and other tissue. Ann NY Acad Sci 180:363–385, 1981

    Google Scholar 

  17. Spannhake EW, Colombo JL, Craigo PA, McNamara DB, Hyman AL, Kadowitz PJ: Evidence for modification of pulmonary cyclooxygenase activity by endotoxin in the dog. J Appl Physiol 54:191–198, 1983

    Google Scholar 

  18. Wise WC, Cook JA, Haluska PW napp DP: Protective effects of thromboxane synthetase inhibitors in rats in endotoxis shock. Circ Res 46:854–859, 1980

    Google Scholar 

  19. Bertele U, De Gaetano G: Potentiation by dazoxiben, a thromboxane synthetase inhibitor of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin. Eur J Pharmacol 85:331–333, 1982

    Google Scholar 

  20. Burke SE, Di Cola G, Lefer AM: Protection of ischemic cat myocardium by CGS 13080, a selective potent thromboxane A2 synthesis inhibitor. J Cardiovasc Pharmacol 5:842–847, 1983

    Google Scholar 

  21. Ku EC, McPherson SE, Signor C, Chertock H, Cash WD: Characterization of imidazo(1,5-a)pyridine-5 hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models. Biochem Biophys Res Comm 112:899–906, 1983

    Google Scholar 

  22. Nadel JA, Tierney DF: Effect of a previous deep respiration on airway resistance in man. J Appl Physiol 16:717–719, 1961

    Google Scholar 

  23. Kerstein MD, Saroyan M, McMullen-Laird M, Hyman AL, Kadowitz PJ, McNamara D: Metabolism of prostaglandins in human saphenous vein. J Surg Res 35:91–100, 1983

    Google Scholar 

  24. Coleman RA, Humphrey PPA, Kennedy I, Levy GP, Lumley P: Comparison of the actions of U46619, a prostaglandin H2 analog, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73:773–778, 1981

    Google Scholar 

  25. Hamberg M: On the formation of thromboxane B2 and 12L hydroxy-5,8,10,14-eicosatetracnoic acid (12 ho-20:4) in tissues from the guinea pig. Biochem Biophys Acta 431:651–654, 1976

    Google Scholar 

  26. Burgess JR, Rao K, Reddy C: Two electron reduction of prostaglandin endoperoxides to PGF by rat liver glutathione-S-transferases. Fed Proc 44:490, 1985

    Google Scholar 

  27. Christ-Hazelhof E, Nugteren DH, van Dorp DA: Conversions of prostaglandin endoperoxides by gluthathione-Stransferases and serum albumins. Biochim Biophys Acta 450:450–461, 1976

    Google Scholar 

  28. Ogino N, Miyamoto T, Yamamoto S, Hayaishi O: Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione requiring enzyme. J Biol Chem 252:890–895, 1977

    Google Scholar 

  29. Shimizu T, Yamamoto S, Hayaishi O: Purification and properties of prostaglandin D synthetase from rat brain. J Biol Chem 254:5222–5228, 1979

    Google Scholar 

  30. Christ-Hazelhof E, Nugteren DH: Purification and characterization of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochem Biophys Acta 572:43–51, 1979

    Google Scholar 

  31. Sun FF: Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane synthetase. Biochem Biophys Res Comm 74:1432–1440, 1977

    Google Scholar 

  32. Akers DL, Kerstein MD, Rush DS, Bellan JA, Haynes DF, Kadowitz PJ, McNamara DB: Prostacyclin and thromboxane A2 formation by atherosclerotic carotid artery: comparison with normal aorta, saphenous vein and platelets. J Vasc Surg (accepted), 1988

  33. Meister A, Anderson ME: Glutathione. Ann Rev Biochem 52:711–760, 1983

    Google Scholar 

  34. McNamara DB, Hussey JL, Kerstein MD, Rosenson Rs, Hyman AL, Kadowitz PJ: Modulation of prostacyclin synthetase and unmasking of PGE2 isomerase in bovine coronary arterial microsomes. Biochem Biophys Res Comm 118:33–39, 1984

    Google Scholar 

  35. McNamara DB, Rush DS, Kerstein MD, Bellan JA, Mayeux PR, Adinolfi MF, Hyman AL, Kadowitz PJ: Prostaglandin endoperoxide metabolism by the human carotid artery. In: RE Beamish, V Pannagia and NS Dhalla (eds) Pathogenesis of Stress-Induced Heart Disease. Martinus Nijhoff Publ, Boston, 1985, pp 333–341

    Google Scholar 

  36. Rush DS, Kerstein MD, Bellan JA, Knoop SM, Mayeux PR, Hyman AL, Kadowitz PJ, McNamara DB: Prostacyclin, thromboxane A2 and prostaglandin E2 formation in atherosclerotic human carotid artery. Arteriosclerosis 8:73–78, 1988

    Google Scholar 

  37. Kerstein M, Kadowitz P, Hyman A, McNamara DB: Prostaglandin endoperoxide metabolism in normal pulmonary tissue from malignant and non-malignant lung. Am Rev Respir Dis 131:A394, 1985

    Google Scholar 

  38. McNamara DB, Laird M, Hyman AL, Kadowitz PJ, Cassin S: Prostaglandin H2 metabolism by fetal, newborn and adult goat lung. Fed Proc 41:1251, 1982

    Google Scholar 

  39. Raz A, Aharony D: Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 → E2 isomerase. Res Comm Pathol Pharmacol 21:507–515, 1978

    Google Scholar 

  40. Bellan JA, Cassin S, Kerstein MD, Rush DL, Hyman AL, Kadowitz PJ, McNamara DB: Pulmonary prostaglandin endoperoxide (PGH2) metabolism in the fetal, 8-day neonatal and adult goat. Circulation 74:11–89, 1986

    Google Scholar 

  41. Tod ML, Cassin S: Thromboxane synthetase inhibition and perinatal pulmonary responses to arachidonic acid. J Appl Physiol 58:710–716, 1985

    Google Scholar 

  42. Spannhake EW, Hyman AL, Kadowitz PJ: Bronchoactive metabolites of arachidonic acid and their role in airway function. Prostaglandins 22:1013–1026, 1981

    Google Scholar 

  43. Underwood DC, Kriseman T, McNamara DB, Hyman AL, Kadowitz PJ: Blockade of thromboxane responses in the airway of the cat by SQ 29,548. J Appl Physiol 62:2193–2200, 1987

    Google Scholar 

  44. Tilden SJ, Underwood DC, Cowen KH, Wegmann MJ, Graybar GB, Hyman AL, McNamara DB, Kadowitz PJ: Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PHH2. J Appl Physiol 62:2066–2074, 1987

    Google Scholar 

  45. Burch RM, Mais DE, Saussy DL Jr, Halushka PU: Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Nat Acad Sci 82:7434–7438, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McNamara, D.B., Harrington, J.K., Bellan, J.A. et al. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080. Mol Cell Biochem 85, 29–41 (1989). https://doi.org/10.1007/BF00223511

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00223511

Key words

Navigation